Salofalk Rectal Suspension - Consumer Medicine Information
|Condition:||Crohn's Disease, Maintenance, Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Colitis, Active, Ulcerative Colitis, Maintenance, Ulcerative Proctitis|
|Form:||Liquid solution, Rectal|
|Ingredients:||mesalamine, carbomer, edetate disodium, potassium acetate, potassium metabisulfite, purified water, sodium benzoate, xanthan gum|
Mesalamine Rectal Suspension USP
2 g/60 g, 4 g/60 g
About this Medication
What the medication is used for
SALOFALK rectal suspension, 4 g/60 g is used in the management of distal ulcerative colitis (inflammation of the lining of the large bowel and rectum) and may also be used in preventing the symptoms of the disease from recurring. SALOFALK rectal suspension (4 g/60 g) can be used in combination with other drugs.
The lower strength of SALOFALK rectal suspension, 2 g/60 g may also be used in preventing the symptoms of distal ulcerative colitis from recurring.
What it does
SALOFALK is believed to work by interfering in the activity of certain mediators of inflammation (e.g., prostaglandins) which helps reduce the inflammation (swelling and pain) in the rectum and lower part of the large bowel.
When it should not be used
SALOFALK should not be used if:
- patients with severe kidney (renal) impairment (GFR<30ml/min/1.73m2) and/or severe liver (hepatic) impairment (see WARNINGS AND PRECAUTIONS).
- You are allergic to mesalamine or to any ingredient in the formulation (see What the non-medicinal ingredients are)
- You have a sensitivity to salicylates, for example acetylsalicylic acid (Aspirin)
- You have stomach or small intestinal ulcers
- You have urinary tract obstructions
- The patient is an infant under two years of age
What the medicinal ingredient is
SALOFALK contains mesalamine (me-SAL-a-meen), also known as 5-aminosalicylic acid, 5-ASA or mesalazine.
What the non-medicinal ingredients are
SALOFALK rectal suspension contains carbomer, edetate disodium, potassium acetate, potassium metabisulfite, purified water, sodium benzoate and xanthan gum. SALOFALK rectal suspension is gluten-free and phthalate-free.
What dosage form it comes in
SALOFALK rectal suspensions, 2 g/60 g and 4 g/60 g areavailable for single-use. Each unit contains a rectal dosing package designed for self-administration and disposal. A removable protective sheath covers the pre-lubricated suspension nozzle until ready for use. A one-way valve allows the suspension to flow from the bottle through the applicator nozzle and into the rectum as the patient squeezes the thin walled collapsible bottle.
Warnings and Precautions
BEFORE you use SALOFALK talk to your doctor or pharmacist if:
- You have a pre-existing liver disease. There have been reports of liver (hepatic) failure and increased liver enzymes in patients treated with 5-ASA or mesalazine (=mesalamine) products.
- You have mild to moderate liver function impairment. Your doctor will decide if this product is right for you.
- You ever had any unusual or allergic reaction to mesalamine (5-ASA), sulfasalazine (SAS), salicylates (Aspirin), or sulphites
- You have liver or kidney disease
- You have bleeding or clotting disorders
- Your doctor has said you have higher than normal blood urea nitrogen (BUN) levels (renal function test)
- You are pregnant or breastfeeding. Mesalamine is excreted in human breast milk. Discuss with your doctor.
WHILE using SALOFALK:
- Discontinue use at first sign of rash or fever.
You may have your blood or urine tested regularly to monitor your kidney function since prolonged use of SALOFALK may damage your kidneys.
Interactions with this Medication
Interaction between azathioprine, 6-mercaptopurine, and aminosalicylates (such as SALOFALK) has been reported.
Drug interactions with coumarin, methotrexate, probenecid, sulfinpyrazone, spironolactone, furosemide, rifampicin, and Varicella Virus Vaccine (chicken pox vaccine) may bepossible.
Possible interference with measurements, by liquid chromatography, of urinary normetanephrine causing a false-positive test result have been observed in patients exposed to sulfasalazine or its metabolite, mesalamine/mesalazine.
Proper Use of this Medication
Usual adult dose
SALOFALK rectal suspension, 4 g/60 g is self-administered on a daily basis during acute episodes of disease. Usually one unit-dose rectal suspension (4 g) is taken upon retiring (bedtime) and best results occur when retained in the rectum during the entire rest period. Discard unused portion.
Prevention or relapses
SALOFALK rectal suspension, 2 g/60 g is self-administered in the same manner as above on a daily basis to prevent relapse (recurrence of symptoms).
Continued use for a certain period may be recommended by your doctor to prevent symptoms from recurring. Check with your doctor should symptoms such as diarrhoea and rectal bleeding recur.
|If you believe you have used too much, or in case of accidental oral ingestion, contact your doctor, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.|
If you miss a dose of SALOFALK, use it as soon as possible, unless it is almost time for the next dose. Do not use two SALOFALK doses at the same time to make up for a missed dose.
How to Use the Rectal Suspension
Best results are achieved if the bowel is emptied immediately before the suspension is given.
- Preparing the medication for administration:
- Shake the bottle well to make sure that the suspension is homogeneous.
- Remove the protective sheath from the applicator tip. Hold the bottle at the neck so as not to cause any of the medication to be discharged.
- Assuming the correct body position:
- Best results are obtained by lying on the left side with left leg extended and the right leg flexed forward for balance, or the other way around if lefthanded.
- An alternative to lying on the left side is the “kneechest” position.
- Administering the rectal suspension:
- Gently insert lubricated applicator tip into the rectum, pointed slightly toward the navel (umbilicus).
- Grasp the bottle firmly, then tilt slightly so that the nozzle is aimed toward the back, and squeeze slowly to instill the medication. Steady hand pressure will discharge most of the suspension. After administering withdraw and discard the used unit.
- Remain in position for at least 30 minutes to allow thorough distribution of the medication internally. Retain the suspension all night, if possible.
NOTE: SALOFALK rectal suspension will cause staining of direct contact surfaces, including but not limited to fabrics, flooring, painted surfaces, marble, granite, vinyl, and enamel.
Side Effects and what to do about them
Rash, fever, and dizziness are common in patients allergic to sulfasalazine. Stop therapy at the first sign of a rash and contact your doctor.
Worsening of ulcerative colitis may occur and may include the following symptoms: abdominal or stomach cramps or pain (severe) and diarrhoea.
Other reported side effects reported with SALOFALK suspension include abdominal pain or discomfort, abdominal cramps, abnormal coloration of the urine, constipation, cough, diarrhoea, dizziness, feeling of incomplete defecation, fever, flatulence, hair loss, headache, itching, lower back pain, rash and stools discoloured.
|Symptom / Effect||Talk with your|
drug and call
your doctor or
as rash, itching,
fever, swelling of
the mouth and
the heart muscle
and lining around
the heart) with
as pain in the
fluid in the lung,
|Unknown||Liver problems |
such as severe
yellowing of the
skin and eyes,
drop in appetite,
|Acute intolerance |
as difficulty in
cough, fever, and
|Aplastic anaemia |
(shortage of one
or more types of
blood cells) with
exertion, rapid or
skin, frequent or
cuts, skin rash,
This is not a complete list of side effects. For any unexpected effects while taking SALOFALK, contact your doctor or pharmacist.
How to Store it
Store SALOFALK rectal suspension at room temperature, preferably under 25°C. The expiration date and lot number are printed on the bottle.
Suspension colour may vary from off white to brown. Keep the medicine from light and air.
Keep out of reach of children.
Reporting Suspected Side Effects
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:
- Report online at
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form and:
- Fax toll-free to 1-866-678-6789, or
- Mail to: Canada Vigilance Program
Postal Locator 0701E
Ottawa, Ontario K1A 0K9
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.
This document plus the full product monograph, prepared for health professionals can be found by contacting the importer, Actavis Specialty Pharmaceuticals Co., at 1-855-892-8766